As IGF-II is overexpressed in several forms of cancer including brain, thyroid and ovarian cancers1,5, and IGF-II signalling promotes cancer cell growth and survival, this signalling pathway is an important target for development of cancer therapies. The gene discussed is IGF2; the disease is cancer.